Free Newsletter
FDA tobacco bill advances in Congress
Just when the FDA is getting plenty of criticism for lackluster oversight of food and drugs, it could be facing a new challenge: regulating tobacco. The House Committee on Energy and Commerce is set to vote this week on legislation that would put tobacco under the aegis of the FDA, and lawmakers say a bill could be on the president's desk before midyear.
The legislation has some strong backers--rep. Henry Waxman, chair of Energy and Commerce; and Sen. Ted Kennedy, to name two. And it's supported by anti-tobacco advocacy groups, not to mention Philip Morris (though other tobacco companies oppose it). It would set up a new FDA office, financed by tobacco industry fees, to oversee cigarettes and other tobacco products. It would have the power to restrain marketing to young people, and could entertain a ban on menthol.
But the bill isn't universally liked. According to the New York Times, public health physicians are among those who don't like the legislation as it's currently written. "This bill will be worse than no bill at all," the group's chairman told the Times.
- read the NYT story
Related Articles:
New push for FDA power over tobacco
House votes to treat tobacco as a drug
Tobacco used to create new cancer vaccine
WHO: Tobacco could kill one billion by 2100
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: